Cargando…
Delivery of Aerosolized Liposomal Amikacin as a Novel Approach for the Treatment of Nontuberculous Mycobacteria in an Experimental Model of Pulmonary Infection
Pulmonary infections caused by nontuberculous mycobacteria (NTM) are an increasing problem in individuals with chronic lung conditions and current therapies are lacking. We investigated the activity of liposomal amikacin for inhalation (LAI) against NTM in vitro as well as in a murine model of respi...
Autores principales: | Rose, Sasha J., Neville, Mary E., Gupta, Renu, Bermudez, Luiz E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4180930/ https://www.ncbi.nlm.nih.gov/pubmed/25264757 http://dx.doi.org/10.1371/journal.pone.0108703 |
Ejemplares similares
-
Pulmonary Deposition and Elimination of Liposomal Amikacin for Inhalation and Effect on Macrophage Function after Administration in Rats
por: Malinin, Vladimir, et al.
Publicado: (2016) -
Surgery in nontuberculous mycobacteria pulmonary disease
por: Lu, Mimi, et al.
Publicado: (2018) -
In Vitro Activity of Benzimidazole (SPR719) Against Clinical Isolates of Nontuberculous Mycobacteria With and Without Clarithromycin or Amikacin Resistance
por: Kim, Dae Hun, et al.
Publicado: (2024) -
Amikacin Liposome Inhalation Suspension (ALIS) Penetrates Non-tuberculous Mycobacterial Biofilms and Enhances Amikacin Uptake Into Macrophages
por: Zhang, Jimin, et al.
Publicado: (2018) -
Nontuberculous Mycobacteria from Household Plumbing of Patients with Nontuberculous Mycobacteria Disease
por: Falkinham, Joseph O.
Publicado: (2011)